CLINICAL_TRIALS
trial_result
· 2015-03-20
Clinical Trial Update: Buspirone in Reducing Shortness of Breath in Patients With Cancer [Phase 2, Phase 3]
Summary
A Phase 2/3 study tested buspirone to reduce shortness of breath in cancer patients; the trial is completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Dyspnea, Pulmonary Complications | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-03-20